These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33550504)

  • 1. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer.
    Ayala de la Peña F; Ortiz-Muñoz B; Quintanar-Verdúguez T; Santotoribio JD; de la Cruz S; Trapé-Pujol J; Galve-Calvo E; Augé-Fradera JM; García-Gómez J; González-Hernández Á
    Clin Transl Oncol; 2021 Jul; 23(7):1272-1280. PubMed ID: 33550504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
    Palacios Calvo J; Albanell J; Rojo F; Ciruelos E; Aranda-López I; Cortés J; García-Caballero T; Martín M; López-García MÁ; Colomer R
    Rev Esp Patol; 2018; 51(2):97-109. PubMed ID: 29602380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
    J Clin Oncol; 1996 Oct; 14(10):2843-77. PubMed ID: 8874347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
    Vera R; Ibarrola-de-Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
    Clin Transl Oncol; 2022 Nov; 24(11):2107-2119. PubMed ID: 36008616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
    Colomer R; Aranda-López I; Albanell J; García-Caballero T; Ciruelos E; López-García MÁ; Cortés J; Rojo F; Martín M; Palacios-Calvo J
    Clin Transl Oncol; 2018 Jul; 20(7):815-826. PubMed ID: 29273958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
    Stearns V; Yamauchi H; Hayes DF
    Breast Cancer Res Treat; 1998; 52(1-3):239-59. PubMed ID: 10066086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
    Vera R; Ibarrola-de Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
    Rev Esp Patol; 2023; 56(1):32-44. PubMed ID: 36599598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour markers in breast cancer.
    Seregni E; Coli A; Mazzucca N;
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S15-22. PubMed ID: 15127239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
    Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
    Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC).
    Barnadas A; Algara M; Cordoba O; Casas A; Gonzalez M; Marzo M; Montero A; Muñoz M; Ruiz A; Santolaya F; Fernandez T
    Clin Transl Oncol; 2018 Jun; 20(6):687-694. PubMed ID: 29139040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
    García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
    Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
    Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
    Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as markers for cancer risk assessment and treatment monitoring.
    Kasimir-Bauer S
    Mol Diagn Ther; 2009; 13(4):209-15. PubMed ID: 19712001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
    García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
    Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
    Trigo J; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
    Clin Transl Oncol; 2022 Oct; 24(10):1890-1902. PubMed ID: 35739348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
    Oaknin A; Guarch R; Barretina P; Hardisson D; González-Martín A; Matías-Guiu X; Pérez-Fidalgo A; Vieites B; Romero I; Palacios J
    Rev Esp Patol; 2018; 51(2):84-96. PubMed ID: 29602379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
    Albanell J; Andreu X; Calasanz MJ; Concha A; Corominas JM; García-Caballero T; López JA; López-Ríos F; Ramón y Cajal S; Vera-Sempere FJ; Colomer R; Martín M; Alba E; González-Martín A; Llombart A; Lluch A; Palacios J
    Clin Transl Oncol; 2009 Jun; 11(6):363-75. PubMed ID: 19531451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
    Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
    Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    Remon J; García-Campelo R; de Álava E; Vera R; Rodríguez-Peralto JL; Rodríguez-Lescure Á; Bellosillo B; Garrido P; Rojo F; Álvarez-Alegret R
    Clin Transl Oncol; 2020 Jun; 22(6):823-834. PubMed ID: 31559582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.